メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
岡崎医療センター
病院局
概要
フィンガープリント
ネットワーク
プロファイル
(9)
研究成果
(162)
フィンガープリント
岡崎医療センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Acute Heart Infarction
78%
Pedicle
66%
Surgery
62%
Myocardial Infarction
58%
Hepatic Vein
57%
Antiplatelet
46%
Hepatectomy
44%
Cholangiocarcinoma
29%
Percutaneous Coronary Intervention
26%
Bleeding
26%
Non ST Segment Elevation Myocardial Infarction
25%
Coronary Artery Disease
24%
Atrial Fibrillation
23%
Hepatocellular Carcinoma
23%
Diabetes Mellitus
21%
Creatine Kinase
21%
Carcinoma
21%
Segmentectomy
21%
Optical Coherence Tomography
21%
Rivaroxaban
21%
Coronary Stenting
21%
Drug Therapy
21%
Clinical Trial
21%
Heart Failure
21%
ST Segment Elevation Myocardial Infarction
21%
Revascularization
20%
Hospital Mortality
20%
Computer Assisted Tomography
19%
Aneurysm
18%
Infection
17%
Laennec
17%
Surgical Anastomosis
16%
Cardiogenic Shock
16%
Cardiovascular System
15%
Adverse Event
15%
Primary Percutaneous Coronary Intervention
15%
Antithrombotic
15%
Meningitis
14%
Artery
14%
Apoplexy
14%
Drug-Eluting Stent
14%
Neoplasm
14%
Lobectomy
13%
Laboratory Medicine
13%
Malignant Neoplasm
13%
Anatomy
13%
Anticoagulation
13%
Group Therapy
12%
Heart Death
12%
Cardiology
12%
Surgical Technique
12%
Open Surgery
12%
Thrombosis
12%
Propensity Score Matching
12%
Acute Decompensated Heart Failure
11%
Acute Coronary Syndrome
11%
Blood Clot Lysis
11%
Minimally Invasive Procedure
11%
Fulminant
10%
Myocarditis
10%
Computed Tomography Angiography
10%
B-Cell Lymphoma
10%
Stenosis
10%
Obstetrics
10%
Cyclin D1
10%
Mantle Cell Lymphoma
10%
Randomized Controlled Trial
10%
Endoscopy
10%
Endometrium
10%
Robot-Assisted Surgery
10%
Carotid Artery Disease
10%
Anaplastic Carcinoma
10%
Tamoxifen
10%
Endometrium Carcinoma
10%
Carcinoma Cell Line
10%
Carcinogenicity
10%
Spinal Hematoma
10%
Multiple Pulmonary Nodules
10%
Hepatobiliary System
10%
Head-down Tilt
10%
Glycocalyx
10%
Bone Marrow Transplantation
10%
Chylous Ascites
10%
Protein Restriction
10%
Maple Syrup Urine Disease
10%
Open Heart Surgery
10%
Aortic Arch
10%
Colorectal Cancer
10%
Hemihepatectomy
10%
Whole Body Radiation
10%
Erythrocytosis
10%
Infective Endocarditis
10%
Pancreas Fistula
10%
Pancreaticoduodenectomy
10%
Endovascular Aneurysm Repair
10%
Secondary Syphilis
10%
Syphilis
10%
Bone Lesion
10%
Liver Metastasis
10%
Methicillin Resistant Staphylococcus Aureus
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Heart Failure
49%
Heart Infarction
39%
Antiplatelet
35%
Chemotherapy
34%
Clinical Trial
34%
Canagliflozin
32%
Bleeding
24%
Non Insulin Dependent Diabetes Mellitus
24%
Acute Coronary Syndrome
22%
Liver Cell Carcinoma
21%
Cardiovascular Disease
21%
Erythrocytosis
21%
Creatine Kinase
21%
Remission
21%
Rivaroxaban
21%
Cardiogenic Shock
19%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Hospital Mortality
17%
ST Segment Elevation Myocardial Infarction
16%
Combination Therapy
16%
Infarction
15%
Statin (Protein)
15%
Adverse Event
15%
Brain Natriuretic Peptide
14%
Overall Survival
14%
Coronary Artery Disease
14%
Disease
13%
Acetylsalicylic Acid
13%
Atrial Fibrillation
13%
Glimepiride
13%
Non ST Segment Elevation Myocardial Infarction
13%
Blood Stasis
12%
Rituximab
10%
Bevacizumab
10%
Atezolizumab
10%
Large Cell Lymphoma
10%
Diabetes Mellitus
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Cytokine
10%
Neoplasm
10%
Carotid Artery Disease
10%
Fluorodeoxyglucose F 18
10%
Creatine Kinase MM
10%
Aneurysm
10%
Transgenic Animal
10%
Acute Myeloid Leukemia
10%
Cyclooxygenase 2
10%
Endometrium Cancer
10%
COX-2 Inhibitor
10%
Pentetic Acid
10%
Nucleoside Diphosphate Kinase A
10%
Enolase
10%
Beta Adrenergic Receptor Blocking Agent
10%
Ezetimibe
10%
Coronary Artery Atherosclerosis
10%
Metastatic Colorectal Cancer
10%
Vasculotropin
10%
Contact Allergy
10%
Adeno Associated Virus
10%
Contact Dermatitis
10%
Liver Metastasis
10%
Hematologic Malignancy
10%
High Density Lipoprotein Cholesterol
10%
Receptor Antagonist
10%
Diuretic Agent
10%
Colorectal Cancer
10%
Observational Study
10%
Zinc Oxide
10%
Ureaplasma
10%
Monotherapy
10%
Antithrombocytic Agent
9%
Unstable Angina Pectoris
9%
Mouse
8%
Lenvatinib
8%
Major Adverse Cardiac Event
8%
Transgenic Mouse
8%
Survival Rate
7%
Heart Ventricle Tachycardia
7%
Heart Failure with Preserved Ejection Fraction
6%
Diseases
6%
Etodolac
5%
Pitavastatin
5%
Low Density Lipoprotein Cholesterol
5%
Antithrombotic Therapy
5%
Graft Versus Host Reaction
5%
Rectum Cancer
5%
Thrombus
5%
Cholelithiasis
5%
Chronic Bronchitis
5%
Pneumoperitoneum
5%
Mortality Rate
5%
Keyphrases
Acute Myocardial Infarction
32%
Japan
28%
Minuet
21%
Revascularization
15%
ST-elevation Myocardial Infarction (STEMI)
15%
Non-ST Elevation MI
13%
Laboratory Medicine
13%
Heart Failure
12%
Cardiogenic Shock
12%
Clinical Outcomes
12%
Long-term Clinical Outcome
11%
Fulminant Myocarditis
10%
Retrospective Analysis
10%
Intravascular Large B-cell Lymphoma (IVLBCL)
10%
Atezolizumab Plus Bevacizumab
10%
Chemotherapy
10%
Minimally Invasive Therapy
10%
Endometrium
10%
Carotid Artery Disease
10%
Undifferentiated Carcinoma
10%
Carcinoma Cell Lines
10%
Carcinogenicity
10%
Spinal Epidural Hematoma
10%
Endometrial Carcinoma
10%
Head down
10%
Dynamic SPECT
10%
Excessive Erythrocytosis
10%
Pulmonary Vascular Reactivity
10%
Calcified Nodule
10%
Bio-Bentall
10%
Optical Coherence Tomography
10%
Rituximab-containing Chemotherapy
10%
Early Regeneration
10%
LHL15
10%
Residual Functional
10%
Hepatic Resection
10%
Induction Failure
10%
Hydrogen Inhalation
10%
Endothelial Glycocalyx
10%
Creatine Kinase Elevation
10%
BCKDH
10%
Maple Syrup Urine Disease
10%
Thrombolysis in Myocardial Infarction Flow
10%
Surgical Anatomy of the Liver
10%
Advanced Cholangiocarcinoma
10%
Repeat Hepatectomy
10%
High DFT
10%
High Defibrillation Threshold
10%
Open Liver Resection
10%
Rechallenge Therapy
10%
Laparoscopic versus Open
10%
MitraClip Implantation
10%
Erythropoietin-producing Hepatocellular Receptor A2
10%
Anatomical Segmentectomy
10%
Pedicle Approach
10%
Off-hours
10%
Open Approach
10%
Nonagenarians
10%
Minimally Invasive Pancreaticoduodenectomy
10%
Central Bisectionectomy
10%
Advanced Hepatocellular Carcinoma
10%
Clinical Impact
10%
Hepatic Sarcoidosis
10%
Shock Failure
10%
Biodegradable Polymer Drug-eluting Stents
10%
Electrode Spacing
10%
Admission Heart Rate
10%
Mapping Catheter
10%
Hepatic Vein
10%
Laparoscopic Approach
10%
Symptom Presentation
10%
Psoriasis Model
10%
Thrombotic Risk
10%
Age Impact
10%
Japanese Patients
10%
Thrombotic Events
10%
Synovial Osteochondromatosis
10%
Debridement
10%
Necrotizing Fasciitis
10%
Glissonean Pedicle
10%
Transvenous Permanent Pacemaker Implantation
10%
Plaque Instability
10%
Prognostic Tool
10%
Stable Cardiovascular Disease
10%
Caudate Lobectomy
10%
Wall Features
10%
Low Attenuation
10%
Aggressive non-Hodgkin Lymphoma
10%
Gender Differences
10%
Dispersion Wave
10%
Elastomeric Scaffold
10%
Clinical Practice
10%
Zinc Oxide Powder
10%
β-Enolase
10%
Myocarditis
10%
Resection
10%
Candle
10%
Pedicle
10%
Cardiac Myxoma
10%
B-cell Markers
10%